Patents Assigned to Fresenius Medical Care Deutschland GmbH
-
Patent number: 12290341Abstract: The present disclosure relates to a method for determining a blood pressure value of a patient. The method comprises a step of determining a pulse course of the patient; a step of determining a reference point in the pulse course within a transition area from systole to diastole of a cardiac cycle of the patient; and a step of determining the blood pressure value based on the determined reference point.Type: GrantFiled: January 29, 2020Date of Patent: May 6, 2025Assignee: Fresenius Medical Care Deutschland GmbHInventors: Zhang Wei, Christof Rüth
-
Patent number: 12290620Abstract: A dialysis machine is provided that includes an apparatus for treating fluids, in particular, for treating water for dialysis. The apparatus includes one or more hollow fiber membrane filters, a plurality of fluid lines, one or more sampling points, and one or more valve connections. The apparatus is configured such that contaminants can concentrate in a first hollow fiber membrane filter and conclusions can be drawn as to the contamination of the water. An analysis value can be determined from samples of concentrated contaminants. A method for monitoring the apparatus for contamination, is also provided.Type: GrantFiled: December 27, 2019Date of Patent: May 6, 2025Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBHInventors: Liubov Smyslova, Gerhard Wiesen
-
Patent number: 12290619Abstract: The invention relates to a method for manufacturing a liquid acid concentrate for hemodialysis machines, with the following steps. In a preliminary step a water source (120), an acid source (130), an electrolyte tank (140) containing a mixture of electrolytes in exactly the quantity needed for the manufacture of the liquid acid concentrate, and a sodium chloride source (150) are connected to a mixing tank (110). During Step a), the quantity of water needed for the manufacture of the batch of liquid acid concentrate is introduced into the mixing tank (110). At Step b), the quantity of acid needed for manufacture the liquid acid concentrate is introduced into the mixing tank (110), the solution is stirred until a homogeneous solution is obtained. Step c) is to repeat Sub-steps c1) and c2) until the electrolyte mixture contained in the electrolyte tank is completely dissolved.Type: GrantFiled: April 25, 2024Date of Patent: May 6, 2025Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBHInventors: Thierry Eyrard, Philippe Laffay, Benoit Luaire
-
Publication number: 20250135082Abstract: This disclosure teaches a system and method for monitoring an extracorporeal blood circuit of a patient and identifying a needle dislodgement. The method includes identifying a potential needle dislodgement event based on changes in pressure of the extracorporeal blood circuit, searching for a heart rate of a patient by analyzing an optical backscatter signal from an optical sensor attached to the extracorporeal blood circuit or by analyzing a pressure signal representative of the pressure in the extracorporeal blood circuit, and verifying the potential needle dislodgement event is a needle dislodgement based on the absence of the heart rate.Type: ApplicationFiled: October 24, 2024Publication date: May 1, 2025Applicants: AWE Technologies LLC, Fresenius Medical Care Deutschland GmbH, Fresenius Medical Care Holdings, Inc.Inventors: Dipen N. SINHA, Robert SCHAEFER, Curtis OSTERHOUDT, Peter G. ESPINA, Martin J. CRNKOVICH, Fei WANG, Steve M. BOWMAN, Martin URBAN
-
Patent number: 12285553Abstract: Dialyzer systems can consolidate multiple technologies and functionalities of blood treatment systems in a significantly integrated fashion. For example, this disclosure describes dialyzer systems that include a magnetically driven and magnetically levitating pump rotor integrated into the dialyzer. Such a dialyzer can be used with treatment modules that include a magnetic field-generating pump drive unit. In some embodiments, the dialyzers include pressure sensor chambers with flexible membranes with which corresponding pressure transducers of the treatment modules can interface to detect arterial and/or venous pressures.Type: GrantFiled: November 9, 2020Date of Patent: April 29, 2025Assignee: Fresenius Medical Care Deutschland GmbHInventors: Alexander Heide, Arne Peters, Dejan Nikolic
-
Patent number: 12285726Abstract: A filter module provides biotechnological filtration possibilities lessening the danger of contamination while achieving an optimum flow profile. The filter module 100 includes filter housing 110, a filter with a bundle of hollow fibres 114 and a centrifugal pump rotor 132. The filter is arranged in the filter housing 110 such that the centrifugal pump rotor 132 forces a biotechnological liquid into the interior of the hollow fibres 114 via an inlet flow path where liquid enters the filter module perpendicular to a longitudinal axis of the filter, flows into a hollow centre of the centrifugal pump rotor and is thereafter deflected to flow parallel to the longitudinal axis of the filter before entering the hollow fibers of the filter flowing parallel to the longitudinal axis. A filtration device 1100, 1200, 1300 includes filter module 100 and a drive unit for magnetically driving the centrifugal pump rotor 132.Type: GrantFiled: November 5, 2020Date of Patent: April 29, 2025Assignees: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH, UNICYTE EV AGInventors: Alexander Heide, Dejan Nikolic
-
Patent number: 12280339Abstract: The invention relates to a method for manufacturing a hollow fiber membrane bundle from a plurality of polysulfone and PVP-based hollow fiber membranes which encompasses the providing of a spinning solution comprising a polysulfone-based material, in particular polysulfone, a vinylpyrrolidone-based polymer, in particular polyvinylpyrrolidone, an aprotic solvent, in particular dimethylacetamide, providing a coagulant liquid comprising water and an aprotic solvent, in particular dimethylacetamide, co-extruding the spinning solution and the coagulant liquid through a concentric annular spinneret into a hollow strand, whereby the cavity of the strand is filled with coagulant liquid, conducting the strand through a precipitation gap, introducing the strand into a precipitating bath comprised substantially of water so as to obtain a hollow fiber membrane, conducting the hollow fiber membranes through at least one rinsing bath and drying the hollow fiber membrane obtained, arranging the resulting hollow fiber membraType: GrantFiled: August 25, 2022Date of Patent: April 22, 2025Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBHInventors: Torsten Keller, Michael Paul, Roland Sander
-
Patent number: 12268801Abstract: The present disclosure pertains to a media supply arrangement for supplying a medical treatment device with a medium, in particular for supplying an extracorporeal blood treatment device with a dialysis medium, wherein an air conditioning device for air conditioning of a medical treatment device coupled to the media supply arrangement is provided.Type: GrantFiled: September 5, 2019Date of Patent: April 8, 2025Assignee: Fresenius Medical Care Deutschland GmbHInventors: Michael Wild, Andreas Leclerc, Carsten Russ
-
Patent number: 12260958Abstract: The invention relates to the field of medical fluid management devices, in particular dialysis machines. The object of the invention is to design methods and devices, such that the monitoring and control of medical fluid management devices from a remote site are possible. To do so, the screen content of the output device of a fluid management device is transmitted at least partially to an output device of a remote control unit. The screen content optionally has user interfaces, which can be selected on the remote control device and lead to changes in the control of the transmitting medical fluid management device.Type: GrantFiled: November 29, 2023Date of Patent: March 25, 2025Assignee: Fresenius Medical Care Deutschland GmbHInventors: Georg Brand, Daniel Hauck, Peter Kloeffel, Thomas Stahl
-
Patent number: 12251505Abstract: A dialysis device for performing a dialysis treatment can include a liquid conducting system, which comprises a first section and a second section. A differential pressure sensor can be included for measuring a differential pressure pdiffm between a first pressure (p1) in the first section of the liquid conducting system and a second pressure (p2) in the second section of the liquid conducting system. A monitoring unit is also provided, which is configured to determine an operating status based on the measured differential pressure pdiffm. A control device is also provided, which is configured to interrupt and/or block the dialysis treatment according to the determined operating status. A display device is also provided, which is configured to output a notification based on the determined operating status.Type: GrantFiled: April 4, 2019Date of Patent: March 18, 2025Assignee: Fresenius Medical Care Deutschland GmbHInventors: Thomas Nürnberger, Stefan Kellermann
-
Patent number: 12233190Abstract: The present invention relates to an insert piece for a blood tubing set that includes a first connection site for connecting a first tubing portion of the blood tubing set to the insert piece; a second connection site for connecting a second tubing portion of the blood tubing set to the insert piece; a third connection site for connecting a third tubing portion of the blood tubing set to the insert piece; a first main line for conducting a first liquid through the insert piece; a second main line for conducting the first liquid through the insert piece; a secondary line for conducting a second liquid into at least one of the first main line, and the second main line; and a connection portion which connects both main lines to each other or to the second connection site.Type: GrantFiled: June 12, 2023Date of Patent: February 25, 2025Assignee: Fresenius Medical Care Deutschland GmbHInventors: Davide Maria Benelli, Massimo Earl Fini, Reinhold Reiter
-
Publication number: 20250049999Abstract: The present invention relates to a medical device, in particular to a dialysis machine, having a hydraulic unit that has a pipe system that is produced by means of an additive production process and whose intermediate spaces are at least partially filled by a matrix. The invention further relates to an associated method.Type: ApplicationFiled: December 19, 2022Publication date: February 13, 2025Applicant: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBHInventors: Winfried BREHM, Matthias FEHLER, Florian WOHLFEIL, Benedict GLASER
-
Publication number: 20250049997Abstract: The invention relates to a device (1) for a medical treatment apparatus for measuring the flow of liquids in a lumen(S) to be inserted, having a receptacle (D) and a first ultrasonic transducer (US1), wherein the receptacle (D) in the device (1) has a first guide side (A) and a second guide side (P), so that an inserted lumen(S) has approximately a trapezoidal course in lateral projection, wherein the first ultrasonic transducer (US1) is arranged at a first trapezoid corner, and wherein the first ultrasonic transducer (US1) in operation is designed to perform a measurement in or against the direction of flow in the lumen(S), respectively. The invention furthermore also relates to an ensemble with a corresponding device and a lumen.Type: ApplicationFiled: December 16, 2022Publication date: February 13, 2025Applicant: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBHInventors: Tobias STOCKERL, Martin URBAN, Arne PETERS
-
Patent number: 12220516Abstract: The present invention relates to an apparatus for sample taking from a fluid-conducting system, wherein the apparatus has at least one adapter which comprises at least one septum and at least one cannula displaceable relative to the septum, wherein the cannula is displaceable such that it penetrates the septum in a sample taking position and does not penetrate the septum in a flushing position; and wherein the adapter has at least one flushing region for a flushing medium which is arranged such that it is in fluid communication with the inner space of the cannula in the flushing position of the cannula; and wherein the apparatus has at least one receiving region having locking means for the fluid-conducting system by which the fluid-conducting system is fixable in a defined position relative to the adapter. The present invention furthermore relates to a blood treatment device and to a method for taking a sample from a fluid-conducting system.Type: GrantFiled: January 5, 2017Date of Patent: February 11, 2025Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBHInventor: Juergen Haecker
-
Publication number: 20250041500Abstract: The invention relates to a flushing connection 2 for a medical treatment device, in particular an extracorporeal blood treatment device, for connecting a connector 14 of a fluid system 15 to be flushed, in particular an extracorporeal blood tubing system, for draining flushing liquid from the fluid system 15 to the medical treatment device. The inventive flushing connection 2 has a housing body 9 comprising a cavity 11 open on a front housing part 9A of the housing body 9 for receiving a flushing liquid, the housing body 9 having a connection part 13 at the front opening 12 embodied for connecting the connector 14 of the fluid system 15 to be flushed or a closure part 13 for liquid-tight closing of the opening 12 of the cavity 11, wherein the housing body 9 has a discharge connection piece 5 for connecting a discharge line 7 of the fluid system 1 of the medical treatment device, which is in fluid connection with the cavity 11.Type: ApplicationFiled: December 6, 2022Publication date: February 6, 2025Applicant: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBHInventor: Peter KLOFFEL
-
Publication number: 20250041495Abstract: A hydraulic system and method are provided for breaking-up, dislodging, removing, and preventing the build-up of biofilm in a dialysate pathway of an extracorporeal blood treatment device. The dialysate pathway can include a dialyzer discharge line, a drain line, a dialyzer feed line, and a bypass system. At least one ultrasonic device can be positioned and configured to generate ultrasonic waves in the dialysate pathway and to propagate the ultrasonic waves along at least a portion of the dialysate pathway. The ultrasonic waves can be used to break-up biofilm. An ionizing electrode pair can also, or instead, be implemented to break-up, dislodge, remove, and prevent a build-up of biofilm. The system and method can particularly be implemented and useful in non-disposable portions of a hydraulic system of an extracorporeal blood treatment device.Type: ApplicationFiled: July 10, 2024Publication date: February 6, 2025Applicants: Fresenius Medical Care Holdings, Inc., Fresenius Medical Care Deutschland GmbHInventors: David Yuds, Martin Crnkovich, Christian Schlaeper
-
Patent number: 12214112Abstract: The present invention relates to a method for checking the conveying accuracy of conveying devices of a blood treatment apparatus. It further relates to a blood treatment apparatus with a control device and/or closed-loop control device, through which the method is effected, a digital storage medium, a computer program product, and a computer program.Type: GrantFiled: January 23, 2020Date of Patent: February 4, 2025Assignee: Fresenius Medical Care Deutschland GmbHInventor: Joachim Noack
-
Publication number: 20250032991Abstract: The invention relates to a hollow fiber membrane filter comprising a plurality of hollow fiber membranes and at least two support rings, wherein the hollow fiber membranes are each enclosed by a respective support ring in a respective end portion of the hollow fiber membrane filter and are cast in a potting mass, wherein the respective support rings have a circumferential projection arranged at the upper edge which projects beyond the outer side of the circumferential side wall of a respective support ring, and wherein the circumferential projection rests on the respective terminal edges of the first and second end portions of the cylindrical housing of the hollow fiber membrane filter.Type: ApplicationFiled: December 16, 2022Publication date: January 30, 2025Applicant: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBHInventors: Michael AMES, Dietmar HANSEL
-
Patent number: 12208187Abstract: In some embodiments, a medical system includes a dialysis machine having at least one outer surface to be disinfected at a given location, at least one disinfection sensor connected to the dialysis machine at the given location, the disinfection sensor including two or more electrode in fluid contact with the outside surface of the dialysis machine, and a conductivity sensor component in electrical contact with the two or more electrodes, the conductivity sensor component configured to send an electrical signal indicating a conductivity of a liquid on an outside surface of the dialysis machine and in contact with the two or more electrodes, a processor configured to receive the electrical signal and thereby determine a disinfection status of the given location, and a user interface configured to indicate the disinfection status of the given location.Type: GrantFiled: November 20, 2023Date of Patent: January 28, 2025Assignees: Fresenius Medical Care Deutschland GmbH, Fresenius Medical Care Holdings, Inc.Inventors: Martin Joseph Crnkovich, Colin Weaver, Christian Schlaeper
-
Patent number: 12208186Abstract: The present invention pertains to an extracorporeal blood treatment device (1), preferably a hemodialysis device, hemofiltration device, or hemodiafiltration device, comprising a fluidic system (2) having a connection point (20) for adding substances, a detection arrangement (4) for detecting a flow of a substance at the connection point (20), wherein the detection arrangement is configured to generate a flow signal, when a flow of a substance is detected at the connection point (20), and a control unit (5), which is communicatively connected to the detection arrangement (4). The control unit (5) is furthermore configured to output a signal (50) in reaction to a received flow signal. The present invention furthermore pertains to a corresponding method for monitoring at least one connection point.Type: GrantFiled: September 16, 2019Date of Patent: January 28, 2025Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBHInventor: Lars Offermanns